Several months after finding himself in the middle of a boardroom ruckus Phillip Frost plans to step down as chairman of Teva Pharmaceuticals by the end of the year according to a filing with the US Securities and Exchange Commission A replacement has not been chosen His pending departure is not a surprise given that he signaled his intent to resign earlier this year But the circumstances leading the yearold to make this decision were tumultuous